Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease

Journal of Infectious Diseases

Volumn 182, Issue 3, 2000, Pages 792-798

  Wilson, Jamie D K ^a   Imami, Nesrina ^a   Watkins, Amanda ^b   Gill, Jas ^a   Hay, Phillip ^c   Gazzard, Brian ^a   Westby, Mike ^b   Gotch, Frances M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ROCHE PRODUCTS LTD   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAG PROTEIN; GLYCOPROTEIN GP 120; INTERLEUKIN 2; INTERLEUKIN 4; NEF PROTEIN;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; MEMORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; COHORT STUDIES; CYTOKINES; DISEASE PROGRESSION; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; VIRAL LOAD;

EID: 0033823570     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315764     Document Type: Article

References (29)

1. + cytotoxic T-cell responses during chronic viral infection
2. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
3. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection
4. Antigenic peptides recognised by T lymphocytes from AIDS viral envelope-immune humans
5. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro
6. HIV-specific lymphoproliferative responses in asymptomatic HIV-infected individuals
7. T cell recognition of HIV synthetic peptides in a natural infection
8. Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV + long-term survivor
9. Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstitution in HIV disease
10. Pathogenesis of human immunodeficiency virus infection
11. + T cells from human immunodeficiency virus-infected asymptomatic individuals
12. + antigen-specific T cells to undergo apoptosis by HIV-infected monocytes: A 2-step mechanism involving the gp120 molecule
13. + T cells, modulated by cytokines and effected by lymphotoxin
14. + T cell responses associated with control of viraemia
15. HIV type 1-specific helper T cells: A critical host defense
16. Pleiotropic and redundancy: T-cell-derived lymphokines in the immune response
17. The cytokine network
18. Tumor necrosis factor and interferon-γ: Relevance for immune regulation and genetic predisposition to autoimmune diseases
19. A Th1→Th2 switch is a critical step in the etiology of HIV infection
20. Constitutive expression of cytokines in lymphoid tissues of HIV-infected individuals: Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals
21. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells
22. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
23. Inhibition of alloreactivity by mAb MR6: Differential effects on IL-2- and IL-4-producing human T cells
24. Novel mechanism for the impairment of cell proliferation in HIV-1 infection
25. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, Ritonavir
26. Preliminary evidence for partial restoration of immune function in HIV type 1 infection with potent antiretroviral therapies: Clues from the 4th Conference on Retroviruses and Opportunistic Diseases
27. + T-cell repertoire that are not immediately restored by antiretroviral or immune-based therapies
28. + T cell homeostasis and functions in advanced HIV disease
29. Induction of HIV-1-specific T-cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy